UCN-01
As of the edition of 20 October 2026, UCN-01 is a small molecule: stopped in 2013; acts on CDK2, CDK4 and CDK6 and 2 more.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Stopped, 2013
- Kind
- Small molecule
- Registered trials
- 22, 3 stopped early
- Disease areas
- Cancer; Blood and lymph; Immune system; Hormones; Urinary and reproductive; Pregnancy and women's health
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Targets
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 1 | 15 | 14 | 0 | 1 |
| Phase 2 | 7 | 4 | 0 | 2 |
| All trials | 22 |